On the Horizon: Asciminib, a New Drug for Treating R/R CML ...Middle East

Medscape - News
A first-in-class STAMP inhibitor, asciminib, shows better efficacy than bosutinib in patients with relapsed/refractory chronic myeloid leukemia in the chronic phase. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( On the Horizon: Asciminib, a New Drug for Treating R/R CML )

Apple Storegoogle play

Also on site :